Zerga, M. (2026). New therapeutic options for relapsed/refractory diffuse large b-cell lymphoma. Treatment with tafasitamab + lenalidomide. Journal of Hematology, 29(3), 61–70. https://doi.org/10.48057/hematologa.v29i3.687